Methods for the generation of chicken monoclonal antibody fragments by phage display.
暂无分享,去创建一个
R. Fuller | C. Barbas | P. Steinberger | C F Barbas | Roberta P. Fuller | C. Rader | J Andris-Widhopf | C Rader | P Steinberger | R Fuller | J. Andris-Widhopf | Jennifer Andris-Widhopf
[1] C. Thompson,et al. Immunoglobulin gene diversification by gene conversion. , 1993, Progress in nucleic acid research and molecular biology.
[2] T Prospero,et al. "Diabodies": small bivalent and bispecific antibody fragments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. Barbas,et al. The Rabbit Antibody Repertoire as a Novel Source for the Generation of Therapeutic Human Antibodies* , 2000, The Journal of Biological Chemistry.
[4] P. Neiman,et al. Somatic diversification of the chicken immunoglobulin light chain gene is limited to the rearranged variable gene segment , 1987, Cell.
[5] C. Barbas. Synthetic human antibodies , 1995, Nature Medicine.
[6] G. M. Griffiths,et al. Molecular events during maturation of the immune response to oxazolone , 1985, Nature.
[7] H R Hoogenboom,et al. Antibody phage display technology and its applications. , 1998, Immunotechnology : an international journal of immunological engineering.
[8] P. Schultz,et al. Expression studies of catalytic antibodies. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Barbas,et al. Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] E. Voss,et al. Variable region primary structures of a high affinity anti-fluorescein immunoglobulin M cryoglobulin exhibiting oxazolone cross-reactivity. , 1989, The Journal of biological chemistry.
[11] C. Milstein,et al. Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. , 1983, Journal of immunology.
[12] A. Avivi,et al. Chicken immunoglobulin gamma‐heavy chains: limited VH gene repertoire, combinatorial diversification by D gene segments and evolution of the heavy chain locus. , 1988, The EMBO journal.
[13] E. Voss,et al. Conversion of an anti-single-stranded DNA active site to an anti-fluorescein active site through heavy chain complementarity determining region transplantation. , 1994, The Journal of biological chemistry.
[14] J. Sharon,et al. Structural characterization of H chain-associated idiotopes of anti-p-azophenylarsonate monoclonal antibodies. , 1990, Journal of immunology.
[15] Philip H. Abelson. Keeping the gates , 1984, Nature.
[16] C. Milstein,et al. Somatic mutation and the maturation of immune response to 2-phenyl oxazolone , 1984, Nature.
[17] D. Hilvert,et al. Selection of Linkers for a Catalytic Single-chain Antibody Using Phage Display Technology* , 1996, The Journal of Biological Chemistry.
[18] C. Thompson,et al. The antigen-binding characteristics of mAbs derived from in vivo priming of avian B cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] Jean-Claude Weill,et al. Somatic hyperconversion diversifies the single VH gene of the chicken with a high incidence in the D region , 1989, Cell.
[20] E. Voss,et al. Anti-fluorescein antibody 3-13 VH gene rearrangement in idiotypically cross-reactive hybridomas. , 1988, Molecular immunology.
[21] C. Hasemann,et al. Mutational analysis of arsonate binding by a CRIA+ antibody. VH and VL junctional diversity are essential for binding activity. , 1991, Journal of Biological Chemistry.
[22] R. Whitley,et al. Humanized antibodies for antiviral therapy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Milstein,et al. mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification , 1983, Nature.
[24] A. Plückthun,et al. The Functional Expression of Antibody Fv Fragments in Ischhuchia coli: Improved Vectors and a Generally Applicable Purification Technique , 1991, Bio/Technology.
[25] I. Sanz,et al. V kappa and J kappa gene segments of A/J Ars-A antibodies: somatic recombination generates the essential arginine at the junction of the variable and joining regions. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[26] Brad Snedecor,et al. High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment , 1992, Bio/Technology.
[27] R. Young,et al. Epitope tagging and protein surveillance. , 1991, Methods in enzymology.
[28] Andrew R. Cherenson,et al. The structure of an antigenic determinant in a protein , 1984, Cell.
[29] S. Tonegawa. Somatic generation of antibody diversity , 1983, Nature.
[30] T. Manser,et al. Different epitope structures select distinct mutant forms of an antibody variable region for expression during the immune response , 1991, The Journal of experimental medicine.
[31] D R Burton,et al. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. , 1995, Journal of molecular biology.
[32] J. Weill,et al. A hyperconversion mechanism generates the chicken light chain preimmune repertoire , 1987, Cell.
[33] J. Weill,et al. The chicken D locus and its contribution to the immunoglobulin heavy chain repertoire , 1991, European journal of immunology.
[34] S. Ho,et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.
[35] P. Hester,et al. Antibodies to the alpha-subunit of insulin receptor from eggs of immunized hens. , 1985, Journal of immunology.
[36] B. Snedecor,et al. High Level Secretion of a Humanized Bispecific Diabody from Escherichia coli , 1996, Bio/Technology.
[37] L. Wysocki,et al. Clustered H chain somatic mutations shared by anti-p-azophenylarsonate antibodies confer enhanced affinity and ablate the cross-reactive idiotype. , 1990, Journal of immunology.
[38] E. Voss,et al. Comparison of variable region primary structures within an anti-fluorescein idiotype family. , 1989, The Journal of biological chemistry.
[39] T. Inoue,et al. Chicken monoclonal antibody isolated by a phage display system. , 1996, Journal of immunology.
[40] T. Manser,et al. Somatic evolution of variable region structures during an immune response. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Young,et al. Selection of specific phage-display antibodies using libraries derived from chicken immunoglobulin genes. , 1995, Journal of immunological methods.
[42] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[43] D. Siegel,et al. Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implications for Rh(D) epitope topology. , 1998 .
[44] C. Barbas,et al. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Kranz,et al. Restricted reassociation of heavy and light chains from hapten-specific monoclonal antibodies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[46] C. Barbas,et al. A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] Hennie R. Hoogenboom,et al. A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies* , 1999, The Journal of Biological Chemistry.
[48] A. George,et al. Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology. , 1997, Journal of immunological methods.
[49] L. Wysocki,et al. Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten. , 1989, Journal of immunology.
[50] C. Barbas,et al. Phage display of combinatorial antibody libraries. , 1997, Current opinion in biotechnology.
[51] S. Spitalnik,et al. Only selected light chains combine with a given heavy chain to confer specificity for a model glycopeptide antigen. , 1998, Journal of immunology.